Method of treating immunoinflammatory bowel disease
US5286731A · kind A · utility
73Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 1992 |
| Grant date | Feb 15, 1994 |
| Priority date | — |
| Expiry date | Aug 17, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of treating immunoinflammatory bowel disease in a mammal in need thereof which comprises administering an antiimmunoinflammatory amount of rapamycin, alone or in combination with cyclosporin A. As such, rapamycin, alone or in combination with cyclosporin A, is useful in treating bowel diseases such as ulcerative colitis, Crohn's disease, ulcerative proctitis, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.